Carbiotix AB
STO: CRBX.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Industrials
- Industry
- Specialty Business Services
- CEO
- Erik Deaner
- Employees
- 8
- Headquarters
- Lund, Sweden
- IPO year
- 2019
- Market cap
- SEK 32.7M
- Website
- http://www.carbiotix.com
Loading CRBX…
Loading profile data…Frequently asked questions about CRBX
What does Carbiotix AB (CRBX.ST) do?
Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.
Where does CRBX.ST trade?
Carbiotix AB (CRBX.ST) trades on the Stockholm Stock Exchange.
What sector is CRBX.ST in?
Carbiotix AB (CRBX.ST) operates in the Industrials sector, specifically in the Specialty Business Services industry.
Who is the CEO of Carbiotix AB?
Erik Deaner is the chief executive officer of Carbiotix AB (CRBX.ST).
Where is Carbiotix AB headquartered?
Carbiotix AB is headquartered in Sweden.
Does CRBX.ST pay a dividend?
Carbiotix AB (CRBX.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRBX.ST go public?
Carbiotix AB (CRBX.ST) completed its initial public offering in 2019.